TY - JOUR
T1 - Endocrinopathies in paediatric-onset neuromyelitis optica spectrum disorder with aquaporin 4 (AQP4) antibody
AU - Hacohen, Yael
AU - Messina, Silvia
AU - Gan, Hoong-Wei
AU - Wright, Sukhvir
AU - Chandratre, Saleel
AU - Leite, Maria Isabel
AU - Fallon, Penny
AU - Vincent, Angela
AU - Ciccarelli, Olga
AU - Wassmer, Evangeline
AU - Lim, Ming
AU - Palace, Jacqueline
AU - Hemingway, Cheryl
N1 - © The Author(s), 2017. The final publication is available via Sage at http://dx.doi.org10.1177/1352458517726593
PY - 2018/4/1
Y1 - 2018/4/1
N2 - The involvement of the diencephalic regions in neuromyelitis optica spectrum disorder (NMOSD) may lead to endocrinopathies. In this study, we identified the following endocrinopathies in 60% (15/25) of young people with paediatric-onset aquaporin 4-Antibody (AQP4-Ab) NMOSD: morbid obesity ( n = 8), hyperinsulinaemia ( n = 5), hyperandrogenism ( n = 5), amenorrhoea ( n = 5), hyponatraemia ( n = 4), short stature ( n = 3) and central hypothyroidism ( n = 2) irrespective of hypothalamic lesions. Morbid obesity was seen in 88% (7/8) of children of Caribbean origin. As endocrinopathies were prevalent in the majority of paediatric-onset AQP4-Ab NMOSD, endocrine surveillance and in particular early aggressive weight management is required for patients with AQP4-Ab NMOSD.
AB - The involvement of the diencephalic regions in neuromyelitis optica spectrum disorder (NMOSD) may lead to endocrinopathies. In this study, we identified the following endocrinopathies in 60% (15/25) of young people with paediatric-onset aquaporin 4-Antibody (AQP4-Ab) NMOSD: morbid obesity ( n = 8), hyperinsulinaemia ( n = 5), hyperandrogenism ( n = 5), amenorrhoea ( n = 5), hyponatraemia ( n = 4), short stature ( n = 3) and central hypothyroidism ( n = 2) irrespective of hypothalamic lesions. Morbid obesity was seen in 88% (7/8) of children of Caribbean origin. As endocrinopathies were prevalent in the majority of paediatric-onset AQP4-Ab NMOSD, endocrine surveillance and in particular early aggressive weight management is required for patients with AQP4-Ab NMOSD.
KW - Journal Article
UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-85043358723&partnerID=MN8TOARS
UR - https://journals.sagepub.com/doi/10.1177/1352458517726593
U2 - 10.1177/1352458517726593
DO - 10.1177/1352458517726593
M3 - Article
C2 - 28803524
SN - 1352-4585
VL - 24
SP - 679
EP - 684
JO - Multiple Sclerosis Journal
JF - Multiple Sclerosis Journal
IS - 5
ER -